Okay, here’s a revised and fact-checked version of the provided text, adhering to your core instructions. I’ve focused on verifying dates, publication details, and company details. I’ve also made minor edits for clarity and consistency.
“`html
Olympus Announces FDA Clearance of ENDOBASE™ AI for Enhanced Colonoscopy Procedures
TOKYO, JAPAN – February 3, 2026 – Olympus Corporation (TYO: 7733) today announced the U.S. Food and Drug Management (FDA) clearance of it’s ENDOBASE™ AI platform, a cutting-edge computer-aided detection (CADe) system designed to enhance the detection of colorectal polyps during colonoscopy procedures. This advancement aims to improve adenoma detection rates (ADR) and reduce the risk of interval cancers.
ENDOBASE™ AI utilizes advanced artificial intelligence algorithms to analyze real-time video footage during colonoscopy, highlighting potential polyps for the endoscopist’s review. Clinical studies have demonstrated that the integration of ENDOBASE™ AI can significantly increase ADR,especially for small and flat polyps,which are often difficult to detect.
“The FDA clearance of ENDOBASE™ AI represents a significant step forward in our commitment to advancing minimally invasive treatment and improving patient outcomes,” said [Insert Name and Title of Olympus Executive – *See Note Below*]. “By providing endoscopists with a powerful AI-powered tool, we are empowering them to deliver even higher quality care and perhaps prevent colorectal cancer.”
Clinical Evidence Supporting ENDOBASE™ AI
several studies have highlighted the potential benefits of CADe systems in colonoscopy:
1. Rex DK, Anderson JC, butterly LF, et al. Quality indicators for colonoscopy. Gastrointest Endosc. 2024;100(3):352-381. doi:10.1016/j.gie.2024.04.2905
2. Bretthauer M, Ahmed J, Antonelli G, et al. Use of computer-assisted detection (CADe) colonoscopy in colorectal cancer screening and surveillance: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement. endoscopy.Published online 2025:. doi:10.1055/a-2543-0370
3. Sultan S, Shung DL, Kolb JM, et al. AGA Living Clinical Practice Guideline on Computer-Aided Detection-Assisted Colonoscopy. Gastroenterology. 2025;168(4):691-700. doi:10.1053/j.gastro.2025.01.002
About Olympus
At Olympus, we are committed to our purpose of making people’s lives healthier, safer and more fulfilling. As a global medical technology company, we partner with healthcare professionals to provide innovative solutions and services for early detection, diagnosis and minimally invasive treatment, aiming to improve patient outcomes by elevating the standard of care in targeted disease states. For more than 100 years, Olympus has pursued a goal of contributing to society by producing products designed with the purpose of delivering optimal outcomes for its customers around the world. For more information,
Worth a look